| Dr Kevin William Wilson, MD | |
|
1700 Old Gatesburg Rd Ste 200, State College, PA 16803-2276 | |
| (814) 237-4321 | |
| (814) 235-0484 |
| Full Name | Dr Kevin William Wilson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 1700 Old Gatesburg Rd Ste 200, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790980381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | MD468320 (Pennsylvania) | Secondary |
| 207X00000X | Orthopaedic Surgery | MD468320 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Nittany Medical Center | State college, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenix Rehabilitation And Health Services Inc | 3476464298 | 51 |
| Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
| Mount Nittany Medical Center Health Services Inc | 8426136797 | 196 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Researchers have found that, contrary to conventional wisdom backed by "a more than 10 percent drop" in physician pay and consumer complaints, doctors are actually spending more time with their patients than they used to, the Los Angeles Times' Booster Shots blog reports.
EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
› Verified 5 days ago
| Entity Name | Mount Nittany Medical Center Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164691499 PECOS PAC ID: 8426136797 Enrollment ID: O20081021000240 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Researchers have found that, contrary to conventional wisdom backed by "a more than 10 percent drop" in physician pay and consumer complaints, doctors are actually spending more time with their patients than they used to, the Los Angeles Times' Booster Shots blog reports.
EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin William Wilson, MD 1700 Old Gatesburg Rd Ste 200, State College, PA 16803-2276 Ph: (814) 237-4321 | Dr Kevin William Wilson, MD 1700 Old Gatesburg Rd Ste 200, State College, PA 16803-2276 Ph: (814) 237-4321 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Researchers have found that, contrary to conventional wisdom backed by "a more than 10 percent drop" in physician pay and consumer complaints, doctors are actually spending more time with their patients than they used to, the Los Angeles Times' Booster Shots blog reports.
EntreMed a clinical-stage pharmaceutical company developing therapeutics primarily for the treatment of cancer and inflammatory diseases, has announced the presentation of positive preclinical results for its lead compound, 2-methoxyestradiol (2ME2), in models of rheumatoid arthritis.
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before January 31, 2011 to shareholders of record as of December 31, 2010.
› Verified 5 days ago
Dr. Dov A Bader, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 112, State College, PA 16803 Phone: 814-865-3566 Fax: 814-863-7803 | |
Dr. Edwin J Rogusky, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Thomas J Ellis, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Dr. Christopher J. Lincoski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Regent Ct, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
James S Martin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Gatesburg Rd Ste 200, State College, PA 16803 Phone: 814-237-4321 Fax: 814-235-0484 | |
Kenneth L Cherry, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 476 Rolling Drive Drive, Suite 200, State College, PA 16801 Phone: 814-231-2101 Fax: 814-231-8569 | |
Paul K Herickhoff, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave Ste 112, State College, PA 16803 Phone: 814-865-3566 Fax: 814-863-7803 |